| AA | arachidonic acid |
| ACE | angiotensin-converting enzyme |
| ACEi | angiotensin-converting enzyme inhibitor |
| ACE2 | angiotensin-converting enzyme type 2 |
| ACF | aorto-caval fistula |
| ANG II | angiotensin II |
| ANG 1-7 | angiotensin 1-7 |
| AT1A | angiotensin II type 1 receptor subtype A |
| AT2 | angiotensin II type 2 receptor |
| CKD | chronic kidney disease |
| CYP | cytochrome P-450 enzyme |
| CYP2C23 | cytochrome P-450 enzyme subfamily 2C23 |
| CYP4A1 | cytochrome P-450 enzyme subfamily 4A1 |
| (+dP/dt)max | maximum rates of pressure rise |
| (−dP/dt)max | maximum rates of pressure fall |
| DHETEs | dihydroxyeicosatrienoic acids |
| EET-A | 14,15-epoxyeicosatrienoic acid analog |
| EETs | epoxyeicosatrienoic acids |
| EDPVR | end-diastolic pressure-volume relationship |
| ESPVR | end-systolic pressure-volume relationship |
| FHH | fawn-hooded hypertensive rats |
| FHL | fawn-hooded low-pressure rats |
| GFR | glomerular filtration rate |
| HanSD | normotensive, transgene-negative, Hannover Sprague-Dawley rats |
| HF | heart failure |
| IKEM | Institute for Clinical and Experimental Medicine |
| LV | left ventricle |
| MAP | mean arterial pressure |
| mRNA | messenger ribonucleic acid |
| NE | norepinephrine |
| PRSW | preload recruitable stroke work |
| RAS | renin-angiotensin system |
| RBF | renal blood flow |
| RDN | renal denervation |
| RSNA | renal sympathetic nerve activity |
| RV | right ventricle |
| sEH | soluble epoxide hydrolase |
| SHR | spontaneously hypertensive rats |
| TGR | Ren2 renin transgenic, hypertensive rats |
| TPR | total peripheral resistance |
| 20-HETE | 20-hydroxyeicosatrienoic acid |